VCM
RCKT icon

Voleon Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Voleon Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Sell
32,458
-17,336
-35% -$57.6K ﹤0.01% 747
2026
Q1 		$178K Sell
49,794
-18,187
-27% -$72.3K ﹤0.01% 759
2025
Q4 		$239K Sell
67,981
-56
-0.1% -$192 0.01% 703
2025
Q3 		$222K Buy
68,037
+28,010
+70% +$88.2K 0.01% 806
2025
Q2 		$98.1K Buy
+40,027
New +$203K 0.01% 469

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Voleon Capital Management's RCKT Position: Q2 2026 in Review

Voleon Capital Management reduced its Rocket Pharmaceuticals (RCKT) stake by 35% in Q2 2026, selling an estimated $57.6K and leaving 32,458 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Voleon Capital Management first reported a position in RCKT in Q2 2025 and has held it in 5 quarters since. The position peaked at $239K in Q4 2025. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Voleon Capital Management held 32,458 shares of Rocket Pharmaceuticals worth $111K as of Q2 2026.
  • Voleon Capital Management sold 17,336 Rocket Pharmaceuticals shares in Q2 2026, an estimated $57.6K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Voleon Capital Management's portfolio in Q2 2026, its #747 holding.
  • Voleon Capital Management first reported a position in Rocket Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Voleon Capital Management's Rocket Pharmaceuticals position peaked at $239K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.